Parkinson's Spread Halted in Labs

By Jordan Kim

Scientists at the University of Pennsylvania have made a groundbreaking discovery, identifying a brain immune protein called GPNMB that is crucial to the spread of Parkinson's disease. This exciting finding reveals that blocking GPNMB with antibodies successfully halted the toxic process between brain cells, offering a promising new avenue for developing treatments to slow the disease's progression.

Scientists at the University of Pennsylvania's Perelman School of Medicine have identified a brain immune protein, GPNMB, crucial to Parkinson's disease spread.
According to ScienceDaily, this protein plays a significant role in how the toxic process of Parkinson's progresses through the brain.
Lab experiments demonstrated that blocking GPNMB with antibodies successfully stopped the toxic process from spreading between brain cells.
This breakthrough offers a promising new avenue for developing treatments for Parkinson's disease.
As reported by ScienceDaily, these potential treatments could specifically aim to slow the disease's progression, particularly in its early stages.

Reporting Sources 1